At this year’s Mayer Brown Utah Life Sciences Summit Dr. David Bearss, CEO of Halia Therapeutics interviews Leslie Stolz, VP Early Innovation Partnering, Johnson & Johnson about rigors of early stage pharmaceutical innovation. Both of these individuals are experienced experts in the field.

Recommended For You

Impact of AI on Regulatory & Quality Professionals

Panel discussion "Impact of AI on Regulatory & Quality P
Clinical Trials Into the Future

Panel discussion "Clinical Trails into the Future" from the

MDR/IVDR Implementation for Decision Makers

Panel discussion "MDR/IVDR Implementation for Decision Maker
The Digital Health Environment, Including Predetermined Changes

Alex Smith, partner at Hogan and Lovells presents "The Digit
From Conception to Launch: The Marketing Thread

Panel discussion "From Conception to Launch: The Marketing T
Developments in Diagnostics

Panel discussion "Developments in Diagnostics" from the 2023